McKesson Ventures Grows Leadership Team with New Partner Promotions

McKesson Ventures has expanded its leadership team, promoting Jennifer Carter and Carrie Hurwitz Williams to partners in the organization. Their promotions reflect McKesson Ventures’ commitment to an apprentice model of mentoring and promoting from within.

Carter brings more than 20 years of healthcare experience, and her expertise spans marketing, business development, and sales operations. She joined McKesson Ventures in 2014 as vice president of portfolio development. In 2019, Carter expanded her role to oversee operations for the firm that include managing talent, budget, and resources. As partner, Carter will take on direct investments and board responsibilities with select companies, in addition to her current role.

“I’m interested in companies that are pushing the boundaries of pharmacy care and are finding new ways to improve access, adherence, and the overall patient experience,” Carter said. “I’m excited to have the opportunity to work closely with entrepreneurs and provide them with support and guidance as they grow their business.”

Williams joined McKesson Ventures in 2017 as principal and has more than 15 years of experience from across the healthcare industry. Her operational and strategic mindset draws upon prior experience with managing clinical trial operations within pharmaceutical and biopharma settings, various roles in parent company McKesson’s strategy and business development team, and as vice president of strategy and business development at Omada Health, with a focus on commercial strategy and partnerships. As partner, Williams will continue to pinpoint strong investment opportunities with a focus on healthcare tech companies on the East Coast.

“I’m naturally drawn to companies that are at the intersection of drug development and technology and companies using technology to enhance patient engagement, care, and improve their healthcare outcomes,” Williams said. “The patient is at the forefront of what we do, so to be able to lead and make investments in this area is a privilege.”

McKesson Ventures has established itself as a leading investor in high-growth companies that are focused on optimizing life-sciences data, technology, and services. The firm also continues to strengthen its presence and expertise in oncology care, consumer health, digital pharmacy, digital supply chain, and value-based care.

Read the original press release here.